T1	Participants 39 102	disseminated small noncleaved-cell lymphoma and B-cell leukemia
T2	Participants 106 135	Children's Cancer Group study
T3	Participants 233 377	patients with disseminated small noncleaved-cell lymphoma and B-cell leukemia who were treated in four successive Children's Cancer Group trials
T4	Participants 403 441	462 patients with disseminated disease
T5	Participants 748 823	All patients received protocol-based systemic and intrathecal chemotherapy.
